No Clinical Advantage of Sublingual Sufentanil vs Oral Oxycodone for Pain Management After TKA
How to Cite
OrthoEvidence. No Clinical Advantage of Sublingual Sufentanil vs Oral Oxycodone for Pain Management After TKA. ACE Report. 2020;9(12):24. Available from: https://myorthoevidene.com/AceReport/Report/12720
Sufentanil sublingual tablet system versus oral oxycodone for management of postoperative pain in enhanced recovery after surgery pathway for total knee arthroplasty: a randomized controlled study.J Exp Orthop. 2020 Dec; 7: 92.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seventy-two patients scheduled for a unilateral total knee arthroplasty were randomized to receive a sublingual sufentanil tablet system (15mcg) or oral oxycodone for post-operative pain management, in addition to a standardized multimodal analgesia protocol. The primary outcome of interest was pain on a numeric rating scale (NRS) at 24 hours post-operation. Secondary outcomes of interest included...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE